WuXi Biologics - Interest Expense

WuXi Biologics's Fiscal Year is From January To December - All Figures are in CNY, Billions.

The item "Interest-Expense" stands at 1.36 Billion Chinese Yuans for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 03/31/2015, the period currently displayed.

WuXi Biologics's second quarter result of 0.7342 Billion CNY for the item "Interest Expense" represents an increase of 249.40 percent compared to it's first quarter result.

Also, WuXi Biologics's second quarter result of 0.7342 Billion CNY for the item "Interest Expense" represents an increase of 527.62 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), WuXi Biologics's second quarter result of 1.36 Billion CNY for the item "Interest Expense" represents an increase of 82.71 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 172.87 percent compared to the value the year prior.
The 1 year change in percent is 172.87.
The 3 year change in percent is 139.57.
The 5 year change in percent is 347.64.
The 10 year change in percent is 42,914.58.

The Serie's long term average value is 0.278 Billion Chinese Yuans. It's latest available value, on 06/30/2025, is 391.28 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2015, to it's latest available value, on 06/30/2025, is +42,999.55%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is 0.0%.